Kaposi's sarcoma at the University Teaching Hospital, Lusaka, Zambia in the antiretroviral therapy era

International Journal of Cancer

Volumn 136, Issue 5, 2015, Pages 1241-1242

  Ngalamika, Owen ^a   Minhas, Veenu ^b   Wood, Charles ^b  

^a UNIVERSITY TEACHING HOSPITAL   (Zambia)

^b UNIVERSITY OF NEBRASKA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AFRICA SOUTH OF THE SAHARA; CANCER INCIDENCE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; KAPOSI SARCOMA; LETTER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RISK FACTOR; SOUTH AFRICA; TEACHING HOSPITAL; UNIVERSITY HOSPITAL; YOUNG ADULT; ZAMBIA; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; SARCOMA, KAPOSI;

ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; SARCOMA, KAPOSI;

EID: 84918497387     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29184     Document Type: Letter

References (5)

1. Bohlius J, Valeri F, Maskew M, et al. Kaposi's Sarcoma in HIV-infected patients in South Africa: multicohort study in the antiretroviral therapy era. Int J Cancer, in press.
2. He F, Wang X, He B, et al. Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang, China. J Med Virol 2007;79:161-6.
3. Klaskala W, Brayfield BP, Kankasa C, et al. Epidemiological characteristics of human herpesvirus-8 infection in a large population of antenatal women in Zambia. J Med Virol 2005;75:93-100.
4. Stolka K, Ndom P, Hemingway-Foday J, et al. Risk factors for Kaposi's sarcoma among HIV-positive individuals in a case control study in Cameroon. Cancer Epidemiol 2014;38:137-43.
5. Uldrick TS, Whitby D. Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma. Cancer Lett 2011;305:150-62.